Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions
- PMID: 19335064
- DOI: 10.1517/14728220902780185
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions
Abstract
Background: The role of the carotid baroreflex in blood pressure regulation has been known for a long time but its effects were thought to be short lived. Recent data indicate that stimulation of carotid baroreceptors may lower blood pressure not only for short periods of time, but also in the long run.
Objective/methods: Recent advances in technology permitted the development of a new device (Rheos) that addresses problems with older devices. Several questions remain to be addressed before Rheos can be used widely, and several potential clinical applications remain to be clarified. This review examines these issues and comprehensively describes this therapeutic approach.
Results/conclusions: The carotid baroreceptor reflex is probably not completely in control of blood pressure. Baroreflexes are one of many control systems acting in concert.
Similar articles
-
Modulation of emetic response by carotid baro- and chemoreceptor activations.Auton Neurosci. 2006 Jul 30;128(1-2):25-36. doi: 10.1016/j.autneu.2005.12.006. Epub 2006 Feb 20. Auton Neurosci. 2006. PMID: 16490404
-
The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension.Curr Vasc Pharmacol. 2014 Jan;12(1):16-22. doi: 10.2174/15701611113119990141. Curr Vasc Pharmacol. 2014. PMID: 23905596 Review.
-
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.Hypertension. 2010 Mar;55(3):619-26. doi: 10.1161/HYPERTENSIONAHA.109.140665. Epub 2010 Jan 25. Hypertension. 2010. PMID: 20101001 Clinical Trial.
-
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.J Hypertens. 2012 Aug;30(8):1665-70. doi: 10.1097/HJH.0b013e3283551f10. J Hypertens. 2012. PMID: 22728906 Clinical Trial.
-
Baroreceptor function during exercise: resetting the record.Exp Physiol. 2006 Jan;91(1):27-36. doi: 10.1113/expphysiol.2005.032102. Epub 2005 Nov 11. Exp Physiol. 2006. PMID: 16284242 Review.
Cited by
-
Association Between Systemic Inflammation, Carotid Arteriosclerosis, and Autonomic Dysfunction.Transl Stroke Res. 2020 Feb;11(1):50-59. doi: 10.1007/s12975-019-00706-x. Epub 2019 May 16. Transl Stroke Res. 2020. PMID: 31093927
-
Common secondary causes of resistant hypertension and rational for treatment.Int J Hypertens. 2011 Mar 2;2011:236239. doi: 10.4061/2011/236239. Int J Hypertens. 2011. PMID: 21423678 Free PMC article.
-
Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.Eur Heart J. 2013 Jul;34(28):2132-40. doi: 10.1093/eurheartj/eht197. Epub 2013 Jun 19. Eur Heart J. 2013. PMID: 23782649 Free PMC article.
-
Autonomic Dysfunction in Sleep Disorders: From Neurobiological Basis to Potential Therapeutic Approaches.J Clin Neurol. 2022 Mar;18(2):140-151. doi: 10.3988/jcn.2022.18.2.140. J Clin Neurol. 2022. PMID: 35274834 Free PMC article. Review.
-
Non-interventional management of resistant hypertension.World J Cardiol. 2014 Oct 26;6(10):1080-90. doi: 10.4330/wjc.v6.i10.1080. World J Cardiol. 2014. PMID: 25349652 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical